Announced Fri, 25 Sept, 2026 · 13:20 IST

All 4 resolutions passed at 34th AGM of Euro Leder Fashion

Board & Shareholder Meetings View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-8.1%Reaction day

₹26.70

prior close

₹24.54

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-8.4% vs market

Gems, Jewellery And Watches peers, median of 39sector+0.0%-8.1% vs sector

On the reaction day the stock moved 8.4 pts less than Nifty Microcap 250 and 8.1 pts less than its Gems, Jewellery And Watches peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-8.1+0.3-8.4+0.0-8.1

Next day

-12.7-1.3-11.4-1.7-10.9

-10.1-0.3-9.9-1.8-8.4

-6.0-0.6-5.4-1.9-4.1

-8.2-1.8-6.4-1.5-6.7

-3.7-1.8-1.8-2.5-1.2

-7.6-0.8-6.8-2.3-5.3

15d

+18.0-4.1+22.1-0.9+18.9

+6.4-9.4+15.7-2.8+9.2

—————

UpDownMarket · Nifty Microcap 250Sector · Gems, Jewellery And Watches peers, median of 39Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Euro Leder Fashion held its 34th AGM on 24 Sept 2026 via video conferencing. All 4 resolutions passed with 99.9986 percent votes in favor (only 22 against out of 1,592,965 polled). Items: adoption of FY26 audited financials, re-appointment of Mr. Kavinesan I.M by rotation, re-appointment of Mr. RM Lakshmanan as MD for 5 years, and re-appointment of Mr. Ravindran Varadarajan as Independent Director for 5 years. 48 shareholders attended.

Likely market impact

Routine AGM with near-unanimous approval. Board continuity confirmed. No material impact on share price expected.